Filing Details
- Accession Number:
- 0001773751-24-000323
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-16 17:50:14
- Reporting Period:
- 2024-10-16
- Accepted Time:
- 2024-10-16 17:50:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1894602 | Irene Becklund | 2269 Chestnut Street, #523 San Francisco CA 94123 | Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2024-10-16 | 471 | $9.41 | 5,587 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2024-10-16 | 471 | $22.64 | 5,116 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-10-16 | 471 | $0.00 | 471 | $9.41 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
944 | 2030-12-22 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2023 by the Reporting Person.
- The shares of Class A common stock vest in a series of forty-eight successive equal monthly installments beginning on February 16, 2021, subject to the Reporting Person's continuous service with the issuer.